close
Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 2014 Aug 12:8:1065-72.
doi: 10.2147/DDDT.S66576. eCollection 2014.

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol

Affiliations
Comparative Study

Optimization of nebulized delivery of linezolid, daptomycin, and vancomycin aerosol

Paul Zarogoulidis et al. Drug Des Devel Ther. .

Abstract

Background: At this time, several antibiotics have been investigated as possibilities for aerosol administration, but local therapy has been found to be more efficient in several diseases.

Materials and methods: The drugs linezolid (Zyvox), vancomycin (Voncon), and daptomycin (Cubicin) were tested with three jet nebulizers with seven different residual cups and different loadings. Moreover, three ultrasound nebulizers were again tested with these drugs, with different loadings and mouthpiece attachments.

Results: When drugs are combined with particular cup designs, they significantly lower the droplet size to 1.60 and 1.80 μm, which represents the best combination of Zyvox and cup G and Cubicin and cup D, respectively. Cup design D is suggested as the most effective cup for lowering the droplet size (2.30 μm) when considering a higher loading level (8 mL).

Conclusion: Modification of current drugs from dry powder to solution is possible, and the residual cup design plays the most important role in droplet size production when the nebulization systems have the same properties.

Keywords: aerosol; daptomycin; jet nebulizers; linezolid; ultrasound nebulizers; vancomycin.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Jet nebulizers.
Figure 2
Figure 2
Large residual cups.
Figure 3
Figure 3
Small residual cups.
Figure 4
Figure 4
Ultrasound nebulizers.
Figure 5
Figure 5
Mastersizer 2000 (Malvern Instruments Ltd, Malvern, Worcestershire, UK).
Figure 6
Figure 6
Residual cups and mass median aerodynamic diameter (MMAD) (F=6, 48).
Figure 7
Figure 7
Residual cups, mass median aerodynamic diameter (MMAD), and drugs.
Figure 8
Figure 8
Large residual cups and mass median aerodynamic diameter (MMAD) (F=2, 8).
Figure 9
Figure 9
Drugs and mass median aerodynamic diameter (MMAD) (F=2, 4).
Figure 10
Figure 10
Drugs and mass median aerodynamic diameter (MMAD) (F=2, 48).

References

    1. Zarogoulidis P, Chatzaki E, Porpodis K, et al. Inhaled chemotherapy in lung cancer: future concept of nanomedicine. Int J Nanomedicine. 2012;7:1551–1572. - PMC - PubMed
    1. Zarogoulidis P, Hohenforst-Schmidt W, Darwiche K, et al. 2-diethylaminoethyl-dextran methyl methacrylate copolymer nonviral vector: still a long way toward the safety of aerosol gene therapy. Gene Ther. 2013;20(10):1022–1028. - PubMed
    1. Zarogoulidis P, Darwiche K, Hohenforst-Schmidt W, et al. Inhaled gene therapy in lung cancer: proof-of-concept for nano-oncology and nanobiotechnology in the management of lung cancer. Future Oncol. 2013;9(8):1171–1194. - PubMed
    1. Zarogoulidis P, Eleftheriadou E, Sapardanis I, et al. Feasibility and effectiveness of inhaled carboplatin in NSCLC patients. Invest New Drugs. 2012;30(4):1628–1640. - PubMed
    1. Patel RB, Smaldone GC, Cuccia AD, Strachan P. In vitro delivery of aerosolized treprostinil via modern mechanical ventilation. J Aerosol Med Pulm Drug Deliv. 2013;26(4):200–207. - PubMed

Publication types

MeSH terms